32 results for «131»
32 results
LIVE demonstration from National University Heart Centre - Singapore (2019) : Left main bifurcation
04 Jul 2019 – From AICT-AsiaPCR 2019

Synergistic use of calcium modification devices for treatment of severely calcified lesion
04 Oct 2024 – From AICT-AsiaPCR 2024
Explore this live educational case from Liverpool Hospital in Sydney, Australia, as we delve into the synergistic use of calcium modification devices for the treatment of severely calcified lesions. Gain insights into the role of intracoronary imaging in selecting the appropriate calcium modification devices and learn...

Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry
17 Sep 2022
Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.

Author

The Leipzig BASILICA experience
09 Nov 2020
The aim of this study was to evaluate the feasibility, efficacy and safety of the bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction (BASILICA) technique during TAVI in an initial cohort at a single European centre.
Authors :

TARGET FFR: A randomized trial of physiology-guided PCI optimization
19 Oct 2020
At TCT Connect 2020, Damien Collison presented the results of the TARGET FFR trial. Carlos Collet provides a summary of the key messages.

Author

STOPDAPT-2 ACS: exploring the limits of short DAPT
31 Aug 2021
Hirotoshi Watanabe (Kyoto, Japan) presented the results of the STOPDAPT-2 ACS trial in a Hot Line session of the ESC Congress 2021. Dejan Milasinovic provides his analysis of this study.

Author

Meril presents successful LANDMARK RCT one-year results at prestigious EuroPCR 2025
21 May 2025

Biocardia receives FDA breakthrough device designation for CardiAMP Cell Therapy System for heart failure
03 Feb 2022

Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial
05 Mar 2023
Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.

Author

ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
07 Nov 2022
Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation.

Author

Transcatheter edge-to-edge repair in patients with severe mitral regurgitation and cardiogenic shock: Insights from the TVT Registry
17 Sep 2022
Mirvat Alasnag provides her take on the TEER Shock study which was presented at TCT 2022 by Mohamad A. Alkhouli.

Author

OPTION-STEMI: Immediate versus staged complete revascularisation during index admission in patients with STEMI and multivessel disease
02 Sep 2025
Mirvat Alasnag provides her take on OPTION-STEMI, presented by Youngkeun Ahn at ESC Congress 2025 in Madrid.

Author

- ← previous
- 1
- 2
- next →